Mengna Zhan - Concepedia

Author

Mengna Zhan

Shanghai Jiao Tong University

Also Known As

Meng-Na Zhan, Mengna Zhan

Publications

502

Citations

H-Index

Concepts

All Affiliations

Shanghai Jiao Tong University Fudan University Zhongshan Hospital Chinese Academy of Sciences Sun Yat-sen University

About

Mengna Zhan is an author at Shanghai Jiao Tong University specializing in medicine, cell biology, and tumor microenvironment.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	50
2	Cell Biology	3	3	50
3	Health Sciences	1	1	16
4	Immunology	1	1	17
5	Pathology	1	1	17

Mengna Zhan

Publications

475

Citations

H-Index

Page 1

	Year	Citations
MicroRNA-494 inhibits breast cancer progression by directly targeting PAK1 Mengna Zhan, Xiaoting Yu, Jun Tang, Cell Death and Disease	2017	117
ANGPTL2/LILRB2 signaling promotes the propagation of lung cancer cells Xiaoye Liu, Xiaoting Yu, Jingjing Xie, Oncotarget	2015	79
TGFB2-AS1 inhibits triple-negative breast cancer progression via interaction with SMARCA4 and regulating its targets<i>TGFB2</i>and<i>SOX2</i> Ci-Xiang Zhou, Difei Wang, Jingchi Li, Proceedings of the National Academy of Sciences	2022	68
MiR-133b targets Sox9 to control pathogenesis and metastasis of breast cancer Qiuyu Wang, Ci-Xiang Zhou, Mengna Zhan, Cell Death and Disease	2018	61
MiR-630 suppresses breast cancer progression by targeting metadherin Ci-Xiang Zhou, Chen-Long Wang, An-Lu Yu, Oncotarget	2015	58
Erlotinib overcomes paclitaxel-resistant cancer stem cells by blocking the EGFR-CREB/GRβ-IL-6 axis in MUC1-positive cervical cancer Yaping Lv, Wei Cang, Quanfu Li, Oncogenesis	2019	42
Reduced expression of BMP3 contributes to the development of pulmonary fibrosis and predicts the unfavorable prognosis in IIP patients Xiaoting Yu, Pan Gu, Ziling Huang, Oncotarget Antifibrotic TherapyInflammatory Lung DiseaseAdvanced Lung DiseaseLung InflammationImmunology	2017	17
Combined LIM kinase 1 and p21-Activated kinase 4 inhibitor treatment exhibits potent preclinical antitumor efficacy in breast cancer Chenchen Zhao, Mengna Zhan, Wan‐Ting Liu, Cancer Letters Breast OncologyP21-activated Kinase 4MedicinePharmacologyInhibitor Treatment	2020	17
LncRNA HABON promoted liver cancer cells survival under hypoxia by inhibiting mPTP opening Lulu Wo, Xin Zhang, Cheng-Ning Ma, Cell Death Discovery Mitochondrial DysfunctionCell DeathHypoxia-induced NecroptosisCancer BiologyTumor Biology	2022	16

Page 1